Find News

Filter articles

Applied Filters

Showing 81 to 90 of 642 results

AbbVie and Pfizer in Humira licensing deal


AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30.

EFPIA concerned over SPC waiver amendments


Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations.

NHS to save £300m in biosimilar adalimumab deals


The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.

EUIPO sides with Takeda in trademark appeal


Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark

EU court sides with Merck in Endoceutics trademark appeal


The EU General Court dismissed Canada-based Endoceutics’ trademark appeal in a win for medical technology company Merck KGaA on Thursday, November 22.

Leo Pharma and PellePharm sign rare disease deal

Denmark, US22-11-2018

Denmark-based Leo Pharma and Californian rare disease company PellePharm have partnered to develop and commercialise therapies for rare forms of skin cancer.

EU court throws out catheter trademark appeal


The EU General Court has upheld a decision to deny Japanese medical device producer Asahi Intecc a trademark for a line of catheters it produces.

LSPN Europe 2018: Russian litigation and US second medical use

Russia, UK, US20-11-2018

The strategies of generic makers in Russia have changed dramatically over the past few years, according to Natalia Gulyaeva, partner at Hogan Lovells.

EU General Court rejects opposition to Merck TM


The EU General Court handed a victory to Merck KGaA late last week, after rejecting a Swiss company’s trademark appeal.

Brexit draft deal: a welcome step but more certainty needed, say lawyers

EU, UK16-11-2018

While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR.

Showing 81 to 90 of 642 results